National Health Investors Inc (NHI) shareholders
Close on Nov 18, 2026Market cap $3.07BP/E 18.0Yield 5.57%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 8,523,688 | 17.60% | 13G (passive) amendment | Jun 30, 2026 |
| Vanguard Portfolio Management | 4,804,502 | 9.78% | 13G (passive) amendment | Sep 30, 2026 |
| State Street Corporation | 2,735,937 | 5.60% | 13G (passive) | Jun 30, 2026 |
| Vanguard Capital Management | 2,475,671 | 5.11% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NHI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8,733,237 | 17.78% | $666.00M | +3,926,380 | 0.01% |
| Vanguard Portfolio Management LLC | 4,630,646 | 9.43% | $353.13M | +488,430 | 0.02% |
| State Street Corp | 2,735,937 | 5.57% | $211.13M | +761,547 | 0.01% |
| Vanguard Capital Management LLC | 2,099,145 | 4.27% | $160.08M | +14,525 | 0.00% |
| Principal Financial Group Inc | 1,977,094 | 4.03% | $150.77M | +276,186 | 0.07% |
| Bank of New York Mellon Corp | 1,606,463 | 3.27% | $122.51M | +1,091,732 | 0.02% |
| Geode Capital Management, LLC | 1,402,775 | 2.86% | $106.99M | +91,535 | 0.01% |
| Bank Of America Corp /De/ | 1,019,379 | 2.08% | $77.74M | +26,577 | 0.01% |
| Charles Schwab Investment Management Inc | 880,321 | 1.79% | $67.13M | +54,330 | 0.01% |
| Nomura Asset Management International Inc. | 870,365 | 1.77% | $66.37M | −26,937 | 0.10% |
| Dimensional Fund Advisors LP | 675,739 | 1.38% | $51.53M | −10,510 | 0.01% |
| Norges Bank | 672,355 | 1.37% | $51.27M | New | 0.01% |
| Northern Trust Corp | 608,688 | 1.24% | $46.42M | +45,841 | 0.01% |
| Morgan Stanley | 444,043 | 0.90% | $33.86M | +64,157 | 0.00% |
| JPMorgan Chase & Co | 415,413 | 0.85% | $32.40M | −571,179 | 0.00% |
| UBS Group AG | 396,229 | 0.81% | $30.22M | +268,595 | 0.00% |
| Two Sigma Investments, LP | 335,445 | 0.68% | $25.58M | −84,629 | 0.02% |
| GW&K Investment Management, LLC | 322,529 | 0.66% | $24.60M | −12,507 | 0.19% |
| Vanguard Fiduciary Trust Co | 321,018 | 0.65% | $24.48M | +9,275 | 0.01% |
| Legal & General Group Plc | 285,144 | 0.58% | $21.75M | +53,401 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 303 | 38M | 77.7% | 42 / 117 | 88 / 54 | 10M | 6M |
| Q1 2026 | 319 | 35M | 70.5% | 55 / 119 | 93 / 26 | 10M | 3M |
| Q4 2025 | 296 | 35M | 70.3% | 48 / 123 | 78 / 29 | 4M | 5M |
| Q3 2025 | 284 | 35M | 72.0% | 37 / 113 | 95 / 25 | 4M | 4M |
| Q2 2025 | 276 | 35M | 70.5% | 26 / 137 | 67 / 32 | 4M | 1M |
| Q1 2025 | 285 | 32M | 64.6% | 43 / 103 | 98 / 31 | 2M | 2M |
| Q4 2024 | 277 | 31M | 63.2% | 37 / 112 | 82 / 37 | 3M | 2M |
| Q3 2024 | 283 | 30M | 61.5% | 68 / 85 | 91 / 15 | 8M | 1M |
| Q2 2024 | 231 | 28M | 56.3% | 34 / 82 | 76 / 22 | 2M | 2M |
| Q1 2024 | 221 | 28M | 56.3% | 34 / 76 | 74 / 21 | 1M | 1M |
| Q4 2023 | 211 | 28M | 56.1% | 25 / 75 | 74 / 22 | 2M | 2M |
| Q3 2023 | 209 | 27M | 54.8% | 17 / 76 | 73 / 17 | 1M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
261 funds held NHI in Q2 2026, 71% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of NHI | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 2,880,051 | 5.86% | $219.63M | 0.20% | Jun 30, 2026 |
| Vanguard Real Estate Index Fund | 1,750,854 | 3.57% | $134.20M | 0.18% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 1,459,676 | 2.97% | $111.31M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,247,631 | 2.54% | $95.14M | 0.11% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,057,147 | 2.15% | $80.62M | 0.04% | Jun 30, 2026 |
| Real Estate Securities Fund | 840,085 | 1.71% | $64.39M | 0.92% | Jul 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 668,967 | 1.36% | $51.02M | 0.08% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 554,654 | 1.13% | $42.30M | 0.04% | Jun 30, 2026 |
| Nomura Small Cap Value Fund | 548,854 | 1.12% | $40.23M | 1.16% | May 29, 2026 |
| Fidelity Small Cap Index Fund | 534,972 | 1.09% | $41.01M | 0.12% | Jul 31, 2026 |
| BNY Mellon Global Infrastructure Income ETF | 523,376 | 1.07% | $40.12M | 3.06% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 459,305 | 0.94% | $35.03M | 0.24% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 445,000 | 0.91% | $33.94M | 0.20% | Jun 30, 2026 |
| Schwab U.S. REIT ETF | 337,242 | 0.69% | $24.72M | 0.25% | May 31, 2026 |
| Vanguard Real Estate Ii Index Fund | 307,320 | 0.63% | $23.56M | 0.21% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| D. Eric Mendelsohn | CEO and President, Director | 133,316 | 0.27% | Jun 5, 2026 |
| Christian Ken Maingot | Chief Operating Officer | 2,370 | 0.00% | Jul 30, 2026 |
| Todd Michael Siefert | Chief Financial Officer | 3,048 | 0.01% | Jul 2, 2026 |
| John L. Spaid | CFO/EVP Finance | 56,287 | 0.11% | May 7, 2026 |
| David L. Travis | SVP/Chief Accounting Officer | 40,565 | 0.08% | May 7, 2026 |
| Kevin Carlton Pascoe | Chief Investment Officer | 73,082 | 0.15% | Mar 30, 2026 |
| Elizabeth Jackson Blankenship | SVP, Legal Affairs | 2,420 | 0.00% | Mar 30, 2026 |
| Kristin Sallee Gaines | SVP/Chief Transaction Officer | 80,277 | 0.16% | Feb 3, 2026 |
| Robert A. McCabe Jr | Director | 44,159 | 0.09% | Jun 15, 2026 |
| James R. Jobe | Director | 33,272 | 0.07% | Jun 9, 2026 |
| Candice W. Todd | Director | 2,563 | 0.01% | Mar 5, 2026 |
| Tracy M. J. Colden | Director | 12,858 | 0.03% | Mar 5, 2026 |
| Lilly Donohue | Director | 1,268 | 0.00% | Mar 5, 2026 |
| Robert Chapin | Director | 1,268 | 0.00% | Mar 5, 2026 |
| Robert G. Adams | Director | 597,644 | 1.22% | Jan 29, 2026 |
| Charlotte A. Swafford | Director | 135,185 | 0.28% | Dec 11, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Christian Ken Maingot Chief Operating Officer | Jul 27, 2026 | Award | +2,370 | – | – | 2,370 |
| Robert A. McCabe Jr Director | Jun 15, 2026 | Buy | +890 | $71.65 | $63.77K | 44,159 |
| James R. Jobe Director | Jun 5, 2026 | Gift | −225 | – | – | 33,272 |
| D. Eric Mendelsohn CEO and President, Director | Jun 5, 2026 | Buy | +1,500 | $68.84 | $103.26K | 133,316 |
| John L. Spaid CFO/EVP Finance | May 5, 2026 | Tax withholding | −314 | $73.09 | $22.95K | 56,287 |
| D. Eric Mendelsohn CEO and President, Director | May 5, 2026 | Tax withholding | −394 | $73.09 | $28.80K | 131,816 |
| David L. Travis SVP/Chief Accounting Officer | May 5, 2026 | Tax withholding | −282 | $73.09 | $20.61K | 40,565 |
| John L. Spaid CFO/EVP Finance | Mar 3, 2026 | Award | +5,072 | – | – | 56,601 |
| Kevin Carlton Pascoe Chief Investment Officer | Mar 3, 2026 | Award | +4,726 | – | – | 73,082 |
| Robert A. McCabe Jr Director | Mar 3, 2026 | Award | +1,268 | – | – | 43,269 |
| Tracy M. J. Colden Director | Mar 3, 2026 | Award | +1,268 | – | – | 12,858 |
| James R. Jobe Director | Mar 3, 2026 | Award | +1,268 | – | – | 1,268 |
| Robert Chapin Director | Mar 3, 2026 | Award | +1,268 | – | – | 1,268 |
| John L. Spaid CFO/EVP Finance | Mar 3, 2026 | Tax withholding | −511 | $86.75 | $44.33K | 54,849 |
| John L. Spaid CFO/EVP Finance | Mar 3, 2026 | Option exercise | +15,000 | $73.34 | $1.10M | 69,849 |
| John L. Spaid CFO/EVP Finance | Mar 3, 2026 | Award | +4,726 | – | – | 55,360 |
| John L. Spaid CFO/EVP Finance | Mar 3, 2026 | Tax withholding | −13,594 | $86.75 | $1.18M | 56,255 |
| Kevin Carlton Pascoe Chief Investment Officer | Mar 3, 2026 | Award | +5,072 | – | – | 73,428 |
| David L. Travis SVP/Chief Accounting Officer | Mar 3, 2026 | Tax withholding | −411 | $86.75 | $35.65K | 40,847 |
| David L. Travis SVP/Chief Accounting Officer | Mar 3, 2026 | Award | +3,458 | – | – | 41,258 |
| Lilly Donohue Director | Mar 3, 2026 | Award | +1,268 | – | – | 1,268 |
| Elizabeth Jackson Blankenship SVP, Legal Affairs | Mar 3, 2026 | Award | +2,420 | – | – | 2,420 |
| Candice W. Todd Director | Mar 3, 2026 | Award | +1,268 | – | – | 2,563 |
| D. Eric Mendelsohn CEO and President, Director | Mar 3, 2026 | Award | +14,409 | – | – | 132,807 |
| D. Eric Mendelsohn CEO and President, Director | Mar 3, 2026 | Tax withholding | −597 | $86.75 | $51.79K | 132,210 |
| David L. Travis SVP/Chief Accounting Officer | Feb 23, 2026 | Option exercise | +8,334 | $57.76 | $481.37K | 57,122 |
| David L. Travis SVP/Chief Accounting Officer | Feb 23, 2026 | Option exercise | +8,333 | $57.76 | $481.31K | 40,455 |
| David L. Travis SVP/Chief Accounting Officer | Feb 23, 2026 | Option exercise | +8,333 | $57.76 | $481.31K | 48,788 |
| David L. Travis SVP/Chief Accounting Officer | Feb 23, 2026 | Tax withholding | −19,322 | $90.03 | $1.74M | 37,800 |
| Kevin Carlton Pascoe Chief Investment Officer | Feb 23, 2026 | Tax withholding | −6,409 | $90.03 | $577.00K | 68,356 |
| Kevin Carlton Pascoe Chief Investment Officer | Feb 23, 2026 | Option exercise | +8,500 | $57.76 | $490.96K | 74,765 |
| D. Eric Mendelsohn CEO and President, Director | Feb 23, 2026 | Tax withholding | −194 | $90.03 | $17.47K | 118,398 |
| D. Eric Mendelsohn CEO and President, Director | Feb 23, 2026 | Tax withholding | −10,192 | $90.03 | $917.59K | 118,592 |
| D. Eric Mendelsohn CEO and President, Director | Feb 23, 2026 | Option exercise | +13,334 | $57.76 | $770.17K | 128,784 |
| John L. Spaid CFO/EVP Finance | Feb 23, 2026 | Tax withholding | −6,312 | $90.03 | $568.27K | 50,870 |
| John L. Spaid CFO/EVP Finance | Feb 23, 2026 | Option exercise | +8,500 | $57.76 | $490.96K | 57,182 |
| John L. Spaid CFO/EVP Finance | Feb 23, 2026 | Tax withholding | −236 | $90.03 | $21.25K | 50,634 |
| Tracy M. J. Colden Director | Feb 19, 2026 | Option exercise | +10,000 | $73.34 | $733.40K | 19,857 |
| Tracy M. J. Colden Director | Feb 19, 2026 | Tax withholding | −8,267 | $88.72 | $733.45K | 11,590 |
| D. Eric Mendelsohn CEO and President, Director | Feb 17, 2026 | Tax withholding | −22,055 | $91.02 | $2.01M | 115,450 |
| D. Eric Mendelsohn CEO and President, Director | Feb 17, 2026 | Option exercise | +25,000 | $73.34 | $1.83M | 137,505 |
| James R. Jobe Director | Feb 17, 2026 | Tax withholding | −8,058 | $91.02 | $733.44K | 33,497 |
| James R. Jobe Director | Feb 17, 2026 | Option exercise | +10,000 | $73.34 | $733.40K | 41,555 |
| Robert A. McCabe Jr Director | Feb 12, 2026 | Option exercise | +10,000 | $73.34 | $733.40K | 50,181 |
| Robert A. McCabe Jr Director | Feb 12, 2026 | Tax withholding | −8,180 | $89.66 | $733.42K | 42,001 |
| Kevin Carlton Pascoe Chief Investment Officer | Feb 11, 2026 | Tax withholding | −13,463 | $88.25 | $1.19M | 66,265 |
| Kevin Carlton Pascoe Chief Investment Officer | Feb 11, 2026 | Option exercise | +15,000 | $73.34 | $1.10M | 79,728 |
| David L. Travis SVP/Chief Accounting Officer | Feb 9, 2026 | Option exercise | +8,333 | $54.73 | $456.07K | 52,656 |
| David L. Travis SVP/Chief Accounting Officer | Feb 9, 2026 | Option exercise | +8,334 | $54.73 | $456.12K | 60,990 |
| David L. Travis SVP/Chief Accounting Officer | Feb 9, 2026 | Tax withholding | −28,868 | $85.10 | $2.46M | 32,122 |
| David L. Travis SVP/Chief Accounting Officer | Feb 9, 2026 | Option exercise | +8,333 | $54.73 | $456.07K | 44,323 |
| David L. Travis SVP/Chief Accounting Officer | Feb 9, 2026 | Option exercise | +2,404 | $53.41 | $128.40K | 26,194 |
| David L. Travis SVP/Chief Accounting Officer | Feb 9, 2026 | Option exercise | +9,796 | $53.41 | $523.20K | 35,990 |
| Candice W. Todd Director | Feb 5, 2026 | Tax withholding | −8,705 | $84.26 | $733.48K | 1,295 |
| Candice W. Todd Director | Feb 5, 2026 | Option exercise | +10,000 | $73.34 | $733.40K | 10,000 |
| Kristin Sallee Gaines SVP/Chief Transaction Officer | Feb 1, 2026 | Option exercise | +18,333 | $53.41 | $979.17K | 80,277 |
| Kristin Sallee Gaines SVP/Chief Transaction Officer | Feb 1, 2026 | Option exercise | +18,334 | $53.41 | $979.22K | 116,944 |
| Kristin Sallee Gaines SVP/Chief Transaction Officer | Feb 1, 2026 | Option exercise | +18,333 | $53.41 | $979.17K | 98,610 |
| Kristin Sallee Gaines SVP/Chief Transaction Officer | Feb 1, 2026 | Option exercise | −43,181 | $82.12 | $3.55M | 73,763 |
| Kevin Carlton Pascoe Chief Investment Officer | Jan 30, 2026 | Option exercise | +8,500 | $57.76 | $490.96K | 78,330 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of National Health Investors's stock actually held short. Settlement fails (shares not delivered on time) peaked at 6,868 shares on Sep 30, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| John L. Spaid Officer | Aug 17, 2026 | 33,124 | $2.40M | Aug 17, 2026 | Restricted Stock Award |
Congress trades
4 trades in National Health Investors reported by 2 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | Bought | Jul 10, 2026 | $1K–15K | Sep 4, 2026 56 days late |
| Gilbert Cisneros CA31 | Bought | Jan 15, 2026 | $1K–15K | Feb 13, 2026 |
| Virginia Foxx NC05 · joint account | Sold | Sep 1, 2022 | $50K–100K | Oct 12, 2022 |
| Virginia Foxx NC05 · joint account | Bought | Jun 28, 2022 | $15K–50K | Jul 5, 2022 |
See a number that looks wrong?